Total Payments
$50,398
2024 Payments
$7,550
Companies
8
Transactions
33
Payment Breakdown by Category
Consulting$37,834 (75.1%)
Research$5,240 (10.4%)
Other$5,240 (10.4%)
Travel$1,432 (2.8%)
Food & Beverage$651.90 (1.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $37,834 | 10 | 75.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,240 | 4 | 10.4% |
| Unspecified | $5,240 | 2 | 10.4% |
| Travel and Lodging | $1,432 | 6 | 2.8% |
| Food and Beverage | $651.90 | 11 | 1.3% |
Payments by Type
General
$45,158
31 transactions
Research
$5,240
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $26,494 | 12 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $7,686 | 6 | $0 (2019) |
| Regeneron Pharmaceuticals, Inc. | $7,445 | 5 | $0 (2024) |
| GlaxoSmithKline, LLC. | $6,058 | 2 | $0 (2020) |
| Regeneron Healthcare Solutions, Inc. | $1,622 | 3 | $0 (2023) |
| PFIZER INC. | $840.00 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $195.12 | 3 | $0 (2024) |
| BOSTON SCIENTIFIC CORPORATION | $58.68 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,550 | 6 | Regeneron Pharmaceuticals, Inc. ($7,445) |
| 2023 | $48.80 | 1 | Regeneron Healthcare Solutions, Inc. ($48.80) |
| 2022 | $856.50 | 2 | PFIZER INC. ($840.00) |
| 2021 | $10,480 | 6 | Teva Pharmaceuticals USA, Inc. ($10,480) |
| 2020 | $6,000 | 1 | GlaxoSmithKline, LLC. ($6,000) |
| 2019 | $9,283 | 9 | Novartis Pharmaceuticals Corporation ($7,686) |
| 2018 | $16,162 | 7 | Teva Pharmaceuticals USA, Inc. ($15,972) |
| 2017 | $17.20 | 1 | Teva Pharmaceuticals USA, Inc. ($17.20) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $2,240.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/22/2024 | Regeneron Pharmaceuticals, Inc. | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $1,680.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/22/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $105.28 | General |
| Category: Respiratory | ||||||
| 01/26/2024 | Regeneron Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,880.00 | General |
| 01/26/2024 | Regeneron Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $940.00 | General |
| 01/26/2024 | Regeneron Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $705.00 | General |
| 05/19/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $48.80 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/24/2022 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $840.00 | General |
| 06/11/2022 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Respiratory | ||||||
| 11/19/2021 | Teva Pharmaceuticals USA, Inc. | — | — | Cash or cash equivalent | $2,620.00 | Research |
| Study: A 16-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Proof-of-Concept Study to Evaluate the Efficacy and Safety of TEV-48574 in Adults With T2-low/Non-T2 Severe Uncontrolled Asthma | ||||||
| 10/21/2021 | Teva Pharmaceuticals USA, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,310.00 | General |
| 10/20/2021 | Teva Pharmaceuticals USA, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,310.00 | General |
| 04/16/2021 | Teva Pharmaceuticals USA, Inc. | — | — | Cash or cash equivalent | $2,620.00 | Research |
| Study: A 16-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Proof-of-Concept Study to Evaluate the Efficacy and Safety of TEV-48574 in Adults With T2-low/Non-T2 Severe Uncontrolled Asthma | ||||||
| 03/29/2021 | Teva Pharmaceuticals USA, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,310.00 | General |
| 03/28/2021 | Teva Pharmaceuticals USA, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,310.00 | General |
| 10/27/2020 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $6,000.00 | General |
| 11/15/2019 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $6,578.00 | General |
| 11/15/2019 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | Cash or cash equivalent | $234.00 | General |
| 11/15/2019 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $171.74 | General |
| 11/15/2019 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $118.16 | General |
| 11/15/2019 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | Cash or cash equivalent | $23.00 | General |
| 11/14/2019 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $561.00 | General |
| 04/12/2019 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $52.93 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/06/2019 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $1,520.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 01/23/2019 | Teva Pharmaceuticals USA, Inc. | PROAIR (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Respiratory | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A 16-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Proof-of-Concept Study to Evaluate the Efficacy and Safety of TEV-48574 in Adults With T2-low/Non-T2 Severe Uncontrolled Asthma | Teva Pharmaceuticals USA, Inc. | $5,240 | 2 |
About Dr. David Peden, MD
Dr. David Peden, MD is a Pediatrics healthcare provider based in Chapel Hill, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417037987.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Peden, MD has received a total of $50,398 in payments from pharmaceutical and medical device companies, with $7,550 received in 2024. These payments were reported across 33 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($37,834).
Ad
Practice Information
- Specialty Pediatrics
- Location Chapel Hill, NC
- Active Since 10/17/2006
- Last Updated 07/08/2007
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1417037987
Products in Payments
- DUPIXENT (Biological) $5,542
- FASENRA (Biological) $105.28
- FASENRA (Drug) $73.34
- GENERAL BRONCHIAL THERMOPLASTY (Device) $58.68
- PROAIR (Drug) $24.00
- TEZSPIRE (Biological) $16.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Chapel Hill
Joseph Muenzer, Md, MD
Pediatrics — Payments: $415,382
Pediatrics $415,382
Dr. Michael Kappelman, Md, MD
Pediatrics — Payments: $92,929
Pediatrics $92,929
Maria Escolar
Pediatrics — Payments: $71,460
Pediatrics $71,460
Dr. Edwin Kim, M.d, M.D
Pediatrics — Payments: $29,015
Pediatrics $29,015
Steven Zeisel, Md, MD
Pediatrics — Payments: $24,726
Pediatrics $24,726
Dr. Thomas Ferkol, Md, MD
Pediatrics — Payments: $14,351
Pediatrics $14,351